The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved.
Company Details
- Employees
- 32
- Founded
- -
- Address
- Larkspur, Ca 94939, Us
- Industry
- Research
- Website
- http://www.gcaresearch.org
- Keywords
- Adaptive Platform Trials, Glioblastoma GBM, Development of Cures for Patients with Rare and Deadly Diseases, Cancer Research, Cancer Policy, Clinical Trials, Cancer Treatment, Patient Information, Medical Research and Development, Funding Innovative Brain Cancer Research, Global Research Collaboration, Fundraising, Advocacy.
- HQ
- Larkspur, CA
Global Coalition For Adaptive Research Questions
Global Coalition For Adaptive Research's website is http://www.gcaresearch.org
Global Coalition For Adaptive Research's LinkedIn profile is https://www.linkedin.com/company/gcaresearch
Global Coalition For Adaptive Research has
32 employees.
View email and phone details for 32
employees at Global Coalition For Adaptive Research.
Global Coalition For Adaptive Research's industry is
Research
Global Coalition For Adaptive Research's top competitors are
Berry Consultants, Llc,
Abbvie,
Cholangiocarcinoma Foundation,
Fortvita Biologics,
Icon Plc,
Valo Health,
Vertex Pharmaceuticals,
Wattev, Inc.,
Wep Clinical,
Oncolytics Biotech Inc..
Global Coalition For Adaptive Research's categories are Research
Global Coalition For Adaptive Research's founding year is 2017
